ASCL1 and small cell lung carcinoma: using SCLC genetically engineered mouse models (GEMM) revealed that MYC activates Notch/REST signaling, prompting the transition of SCLC from an ASCL1+ to a NEUROD1+ and eventually to a YAP1+ state.